 |
 |
 |
Objective of the Issue
IPO is an offer for sale only .The company will not receive any proceeds of the Offer for Sale by the Selling Shareholders.
IPO Details, Price, Market Lot
| Anthem Biosciences IPO Details | |
| IPO Open Date | 14 July 2025 |
| IPO Close Date | 16 July 2025 |
| IPO Issue Size | 5,95,61,404 Shares (Aggregating up to ₹3,395.00 Cr) |
| Fresh Issue | NIL |
| Offer for Sale | 5,95,61,404 Shares (Aggregating up to ₹3,395.00 Cr) |
| Retail Portion | Not less than 35.00% of the offer |
| NII Portion | Not less than 15.00% of the offer |
| QIB Portion | Not more than 50.00% of the offer |
| Listing At | NSE, BSE |
| Anthem Biosciences IPO Price | |
| Face Value | ₹2 Per share |
| IPO Price Band | ₹540 to ₹570 Per share |
| Employee Discount | ₹50.00 |
| Lot Size | 26 Shares |
| IPO Issue Type | Book Built Issue |
| Anthem Biosciences IPO Time Table (Tentative) | |
| IPO Open Date | 14 July 2025 |
| IPO Close Date | 16 July 2025 |
| Basis of Allotment Date | 17 July 2025 |
| Initiation of Refunds | 18 July 2025 |
| Credit of Share to Demat Account | 18 July 2025 |
| IPO Listing Date | 21 July 2025 |
| Company Promotor & Promotor’s Holding | |
| Ganesh Sambasivam, K Ravindra Chandrappa, Ajay Bhardwaj and Ishaan Bhardwaj are the promoters of the company. | |
| Pre Issue Promotor Holding | 76.87% |
| Post Issue Promotor Holding | 74.68% |
| Company’s Contact & Address | |
|
Anthem Biosciences Ltd. No. 49, F1 & F2, Canara Bank Road, Bommasandra Industrial Area, Phase 1, Bommasandra, Bengaluru, Karnataka, 560099 Phone: +91 080 6672 400 Email: investors.abl@anthembio.com Website: https://www.anthembio.com/ |
|
| Anthem Biosciences IPO Registrar, Lead Manager, Prospectus | |
| IPO Prospectus | |
| IPO Registrar | |
| Kfin Technologies Limited | |
| IPO Lead Manager | |
|
|
Anthem Biosciences IPO Lot Size
| Number of Shares Per Lot = 26 Shares | |||
| Application | Lot(s) | Shares | Amount |
| Retail (Minimum) | 1 | 26 | ₹14,820 |
| Retail (Maximum) | 13 | 338 | ₹1,92,660 |
| S-HNI (Minimum) | 14 | 364 | ₹2,07,480 |
| S-HNI (Maximum) | 67 | 1,742 | ₹9,92,940 |
| B-HNI (Minimum) | 68 | 1,768 | ₹10,07,760 |
| Number of Shares Per Lot = 26 Shares | |||
| Application | Lot(s) | Shares | Amount |
| Retail (Min) | 1 | 26 | ₹14,820 |
| Retail (Max) | 13 | 338 | ₹1,92,660 |
| S-HNI (Min) | 14 | 364 | ₹2,07,480 |
| S-HNI (Max) | 67 | 1,742 | ₹9,92,940 |
| B-HNI (Min) | 68 | 1,768 | ₹10,07,760 |
Anthem Biosciences Financial Report (Restated)
| Period Ended |
Assets (₹ in Crore) |
Revenue (₹ in Crore) |
P A T (₹ in Crore) |
Net Worth (₹ in Crore) |
Borrowings (₹ in Crore) |
| 31 March 2025 | 2,807.58 | 1,930.29 | 451.26 | 2,409.86 | 108.95 |
| 31 March 2024 | 2,398.11 | 1,483.07 | 367.31 | 1,924.66 | 232.53 |
| 31 March 2023 | 2,014.46 | 1,133.99 | 385.19 | 1,740.67 | 125.06 |
| Period Ended | 31 March 2025 | 31 March 2024 | 31 March 2023 |
| Assets | 2,807.58 | 2,398.11 | 2,014.46 |
| Revenue | 1,930.29 | 1,483.07 | 1,133.99 |
| P A T | 451.26 | 367.31 | 385.19 |
| Net Worth | 2,409.86 | 1,924.66 | 1,740.67 |
| Borrowings | 108.95 | 232.53 | 125.06 |
| Amount in ₹ Crore | |||